Stay updated with breaking news from Bob Dagher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A conference call and webcast will be held Tomorrow, April 9, at 8:00 a.m. Eastern Time NEW YORK, April 8, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of cellular...
As the new executive VP and chief development officer of BrainStorm, Dagher is tasked with securing FDA approval of NurOwn for the treatment of ALS.
FDA advisory committee meeting to discuss NurOwn® for Amyotrophic Lateral Sclerosis scheduled for September 27, 2023 BrainStorm's Biologics License Application for NurOwn has a Prescription... -Today at 07:06 am- MarketScreener
Psychedelic drugs and therapy are fueling the conversations on potentially revolutionary treatment and a paradigm shift for mental health disorders.
Press release content from Business Wire. The AP news staff was not involved in its creation.